MedPath

MEDIPLEX 655 - LIQ

MEDIPLEX 655 - LIQ

Discontinued
DIN Number

02117061

Drug Class

Human

Market Date

Dec 19, 1996

Company
HC

mediherb inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02117061
AIG Number0926512001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification

ACTIVE INGREDIENTS (9)

BARIUM CARBONATEActive
Strength: 8 X / ML
Monograph: BARIUM CARBONATE
CALCIUM FLUORIDEActive
Strength: 8 X / ML
Monograph: CALCIUM FLUORIDE
GELSEMIUM SEMPERVIRENSActive
Strength: 8 X / ML
Monograph: GELSEMIUM SEMPERVIRENS
GINSENGActive
Strength: 3 X / ML
Monograph: GINSENG
PHOSPHORIC ACIDActive
Strength: 10 X / ML
Monograph: PHOSPHORIC ACID
POTASSIUM CHLORIDEActive
Strength: 8 X / ML
Monograph: POTASSIUM CHLORIDE
POTASSIUM PHOSPHATE DIBASICActive
Strength: 10 X / ML
Monograph: POTASSIUM PHOSPHATE DIBASIC
SILICON DIOXIDEActive
Strength: 8 X / ML
Monograph: SILICON DIOXIDE
SODIUM CHLORIDEActive
Strength: 8 X / ML
Monograph: SODIUM CHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.